Solid pharmaceutical formulations comprising modafinil

Details for Australian Patent Application No. 2002318155 (hide)

Owner Cephalon, Inc.

Inventors Corvari, Vincent; Parikh, Alpa; Grandolfi, George

Agent Watermark

Pub. Number AU-B-2002318155

PCT Number PCT/US02/16369

PCT Pub. Number WO2002/096401

Priority 10/155,913 23.05.02 US; 60/293,695 25.05.01 US

Filing date 23 May 2002

Wipo publication date 9 December 2002

Acceptance publication date 1 March 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/26 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 10/155,913 23.05.02 US; 60/293,695 25.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002318155

1 March 2007 Application Accepted

  Published as AU-B-2002318155

28 June 2007 Standard Patent Sealed

25 October 2007 Application for Amendment

  The nature of the amendment is: Amend filing date from 23 May 2002 to 24 May 2002.. Address for service in Australia - Watermark Patent & Trademark Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

7 February 2008 Amendment Made

  The nature of the amendment is: Amend the filing date from 23 May 2002 to 24 May 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318156-VEHICLE MONITORING SYSTEM

2002318154-Method and apparatus for reducing pathogens in a biological sample